SciELO - Scientific Electronic Library Online

vol.68 issue1Giant pleomorphic breast sarcomaPerioperative management in patients with thyroid disorders and chronic glucocorticoid therapy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Revista chilena de cirugía

On-line version ISSN 0718-4026


DROPPELMANN M, Nicolás et al. New systemic therapies for melanoma. Rev Chil Cir [online]. 2016, vol.68, n.1, pp.81-86. ISSN 0718-4026.

Abstract Melanoma represents a disease with high tendency to metastasize locally, regionally to the lymph nodes, and systemically to lungs, liver, brain and bone. The surgical treatment has been the cornerstone to treat melanoma patients, with excellent results in early stage, but with poor effectiveness in advance disease with systemic metastases. Traditional chemotherapy with cytotoxic agents has shown little impact on stage IV patients, which has motivated new investigation and innovation in this field. During last 4 years, FDA has approved new therapies for the treatment of metastatic or unresectable melanoma, mostly based in immunotherapy and signal transduction inhibitors, with very promising results. The surgeons treating these patients must be updated about these new therapies, which represent a new treatment opportunity for our patients.

Keywords : Melanoma; metastatic; immunotherapy; chemotherapy; treatment; new advances.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License